Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis
Researchers at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient’s precise biology. Findings were published in Physiological Genomics.
“Our findings pave the way to precision medicine for cystic fibrosis patients, eventually helping us match treatment to each patient’s unique genomic pattern of disease,” says lead author Hara Levy, MD, MMSc, from Manne Research Institute at Lurie Children’s, who is an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. “Our study was the first to identify molecular signatures of cystic fibrosis from a blood test taken during a routine clinic visit, giving us a baseline. Greater understanding of these molecular signatures may lead to unique molecular markers that could help us intervene earlier to changes in a patient’s inflammatory response to airway infection or pancreatic function, allowing us to provide more focused treatment. It would be a huge improvement over the one-size-fits-all treatment approach we currently have for patients with cystic fibrosis.”
To identify baseline molecular signatures in cystic fibrosis, Dr. Levy’s lab obtained genomic information from patients’ blood samples using cutting-edge technologies such as Affymetric array and Illumina MiSeq. The team then merged this genomic information with each individual’s clinical history gathered from electronic medical records. They compared this snapshot of patient-specific data with healthy controls. Their study provides strong evidence for distinct molecular signatures in cystic fibrosis patients that correlate with clinical outcomes.
Cystic fibrosis is a progressive genetic disease that damages multiple organs, including the lungs and pancreas. Currently, the average predicted survival is 47 years. Although cystic fibrosis is caused by dysfunction of a single gene (CFTR) and treatment that targets CFTR mutations is available, the relationships between the abnormal gene product, development of inflammation and disease progression are not fully understood. This limits the ability to predict a patient’s clinical course, provide individualized treatment and rapidly monitor treatment response.
For example, it is not clear why patients with cystic fibrosis are susceptible to chronic lung infections, since they are considered to have a functional immune system.
“We are now trying to discover why patients with cystic fibrosis become infected so easily,” says Dr. Levy. “We are taking a closer look at the immune cells that make up many of the molecular signatures we found in cystic fibrosis.”
More study is needed before precision medicine for cystic fibrosis reaches the clinic.
“With more research, a blood test to gather genomic specifics of each patient’s disease might be available in the clinic within the next five years,” says Dr. Levy. “Precision medicine will revolutionize care for cystic fibrosis patients.”
Learn more: Blood Test Could Lead to Cystic Fibrosis Treatment Tailored to Each Patient
The Latest on: Cystic fibrosis
[google_news title=”” keyword=”cystic fibrosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cystic fibrosis
- Chapel Hill drugmaker sees positive results for lung disease treatmenton May 1, 2024 at 12:16 pm
"These results show that Arina-1 can have a profound benefit for patients," CEO Dan Copeland said in a statement. "There are currently no approved therapies for bronchiectasis, and to see such a clear ...
- May is Cystic Fibrosis Awareness monthon May 1, 2024 at 11:55 am
The Northern Michigan Public Health Alliance (NMPHA), in partnership with (DHD#10), is recognizing Cystic Fibrosis (CF) Awareness Month. Throughout the month, the NMPHA and DHD#10 urges ...
- A New Delivery System Offers Hope for Cystic Fibrosison May 1, 2024 at 7:52 am
CRISPR-carrying lipid nanoparticles enabled researchers to correct a rare nonsense mutation in the lungs of a cystic fibrosis mouse model.
- Her Daughter Died From a Chronic Illness — Now, She's Sharing Her Diaryon May 1, 2024 at 4:45 am
Diane Shader Smith was at a bris ceremony celebrating the birth of her friend's baby boy when she got the call that her then 3-year-old daughter Mallory had been diagnosed with cystic fibrosis. "We ...
- Cystic fibrosis patients may have a high prevalence of developmental defect of enamel, reveals studyon April 30, 2024 at 8:30 am
Cystic fibrosis patients may have a high prevalence of developmental defects of enamel, according to a study published in the Journal of Dentistry.Cystic Fibrosis is an autosomal ...
- Man to cycle 530 kilometres to save next generation of cystic fibrosis suffererson April 30, 2024 at 7:52 am
Devoted dad Bob Clarke is cycling 530 kilometres from Vietnam’s Ho Chi Minh To Angkor Wat in Cambodia … to save cystic fibrosis patients like his treasured daughter. And CF-sufferer Sophie Clarke, 29, ...
- Organization Tips for Parents of Children With CFon April 30, 2024 at 2:00 am
Caring for a child with CF can be a lot to juggle — from the many medications and daily treatments to the endless doctor's appointments. But I’ve found a system that helps me stay organized and stress ...
- Researchers explore new cell target for cystic fibrosis treatmenton April 29, 2024 at 9:54 am
A team of University of Saskatchewan (USask) researchers are exploring the role of a newly identified cell type in cystic fibrosis (CF), which could lead to effective new types of treatment.
- Knoxville community rallies to find cure for cystic fibrosison April 29, 2024 at 5:43 am
Leaders in our community say it'll take everyone coming together to finally find a cure for cystic fibrosis, which is why the Tennessee chapter of the Cystic Fibrosis Foundation is hosting the East ...
- From mentorship to marriage: A lung transplant love storyon April 28, 2024 at 8:39 am
Married since 2005, Gary and Carrie's bond is unbreakable, forged by their shared experiences. ST. LOUIS — After meeting through BJC's Lung Transplant mentoring program, two patients fell in love and ...
via Bing News